Skip to main content

Myelofibrosis clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies

    Sorry, in progress, not accepting new patients

    This is a Phase 1 cohort, dose-escalation, dose-expansion study of PRT543 in patients with advanced cancers who have exhausted available treatment options. The purpose of this study is to define a safe dose and schedule to be used in subsequent development of PRT543.

    San Francisco, California and other locations

Our lead scientists for Myelofibrosis research studies include .

Last updated: